BTK and rheumatoid arthritis: The effects of BTK inhibitors at reducing the osteoclast differentiation in RA is consistent with the hypothesis discussed previously in this paper that BTK inhibitor efficacy requires longer treatment periods in order to reflect processes of B-cell and myeloid cell differentiation rather than the shorter times used to measure steroids and anti-TNFα biologics treating inflammation.